Response to dasatinib in a patient with SQCC of the lung harboring a discoid-receptor-2 and synchronous chronic myelogenous leukemia
V Pitini, C Arrigo, C Di Mirto, P Mondello, G Altavilla - Lung Cancer, 2013 - Elsevier
V Pitini, C Arrigo, C Di Mirto, P Mondello, G Altavilla
Lung Cancer, 2013•ElsevierWe report a patient with squamous cell carcinoma (SQCC) of the lung and a discoid-
receptor-2 (DDR2) kinase domain mutation that responded to dasatinib treatment. Our case
report is consistent with previous publications suggesting that DDR2 mutation may confer
sensitivity to dasatinib.
receptor-2 (DDR2) kinase domain mutation that responded to dasatinib treatment. Our case
report is consistent with previous publications suggesting that DDR2 mutation may confer
sensitivity to dasatinib.
Abstract
We report a patient with squamous cell carcinoma (SQCC) of the lung and a discoid-receptor-2 (DDR2) kinase domain mutation that responded to dasatinib treatment. Our case report is consistent with previous publications suggesting that DDR2 mutation may confer sensitivity to dasatinib.
Elsevier